DK1333026T3 - Fremgangsmåde til fremstilling af perindopril med höj renhed og nyttige mellemforbindelser til syntesen - Google Patents

Fremgangsmåde til fremstilling af perindopril med höj renhed og nyttige mellemforbindelser til syntesen

Info

Publication number
DK1333026T3
DK1333026T3 DK02290206T DK02290206T DK1333026T3 DK 1333026 T3 DK1333026 T3 DK 1333026T3 DK 02290206 T DK02290206 T DK 02290206T DK 02290206 T DK02290206 T DK 02290206T DK 1333026 T3 DK1333026 T3 DK 1333026T3
Authority
DK
Denmark
Prior art keywords
synthesis
preparation
high purity
useful intermediates
purity perindopril
Prior art date
Application number
DK02290206T
Other languages
Danish (da)
English (en)
Inventor
Gyula Simig
Tibor Mezei
Marta Porcs-Makkay
Attila Mandi
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1333026T3 publication Critical patent/DK1333026T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02290206T 2002-01-30 2002-01-30 Fremgangsmåde til fremstilling af perindopril med höj renhed og nyttige mellemforbindelser til syntesen DK1333026T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02290206A EP1333026B1 (fr) 2002-01-30 2002-01-30 Procédé de préparation de perindopril de grande pureté et des intermédiaires utiles dans la synthèse

Publications (1)

Publication Number Publication Date
DK1333026T3 true DK1333026T3 (da) 2007-10-22

Family

ID=8185713

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02290206T DK1333026T3 (da) 2002-01-30 2002-01-30 Fremgangsmåde til fremstilling af perindopril med höj renhed og nyttige mellemforbindelser til syntesen

Country Status (36)

Country Link
US (2) US7326794B2 (fr)
EP (1) EP1333026B1 (fr)
JP (1) JP4171423B2 (fr)
KR (1) KR100673701B1 (fr)
CN (1) CN1300111C (fr)
AP (1) AP1741A (fr)
AR (1) AR038340A1 (fr)
AT (1) ATE365714T1 (fr)
AU (1) AU2003206055B2 (fr)
BG (1) BG66126B1 (fr)
BR (2) BRPI0307293B1 (fr)
CA (1) CA2474003C (fr)
CY (1) CY1106721T1 (fr)
CZ (1) CZ305892B6 (fr)
DE (1) DE60220877T2 (fr)
DK (1) DK1333026T3 (fr)
EA (1) EA009277B1 (fr)
EE (1) EE05428B1 (fr)
ES (1) ES2289060T3 (fr)
GE (1) GEP20063899B (fr)
HK (1) HK1076101A1 (fr)
HR (1) HRP20040781B8 (fr)
HU (1) HU227591B1 (fr)
ME (1) ME00444B (fr)
MX (1) MXPA04007444A (fr)
NO (1) NO330223B1 (fr)
NZ (1) NZ534168A (fr)
OA (1) OA12759A (fr)
PL (1) PL212354B1 (fr)
PT (1) PT1333026E (fr)
RS (1) RS52465B (fr)
SI (1) SI1333026T1 (fr)
SK (1) SK287866B6 (fr)
UA (1) UA77756C2 (fr)
WO (1) WO2003064388A2 (fr)
ZA (1) ZA200405548B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4677611B2 (ja) * 2003-10-21 2011-04-27 レ ラボラトワール セルヴィエ 結晶ペリンドプリルエルブミンの新規な調製方法
SI21704A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
LT1729739T (lt) * 2004-03-29 2016-11-10 Les Laboratoires Servier Kietos farmacinės kompozicijos gamybos būdas
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
ES2255872B1 (es) * 2004-12-31 2007-08-16 Quimica Sintetica, S.A. Procedimiento para la preparacion de perindopril erbumina.
PT1679072E (pt) 2005-01-06 2008-12-22 Ipca Lab Ltd Processo para a síntese de derivados de ácido (2s,3as,7as)-1-(s)-alanil-octa-hidro-1h-indole-2-carboxílico e utilização na síntese de perindopril
US7710739B2 (en) 2005-04-28 2010-05-04 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device and display device
WO2006137082A1 (fr) * 2005-06-23 2006-12-28 Ramesh Babu Potluri Procédé pour la préparation de périndopril erbumine viable industriellement
US20070032661A1 (en) * 2005-08-03 2007-02-08 Glenmark Pharmaceuticals Limited Process for the preparation of intermediates of perindopril
WO2007020012A1 (fr) * 2005-08-12 2007-02-22 Lek Pharmaceuticals D.D. Procede de preparation de perindopril erbumine
EP1792896A1 (fr) * 2005-12-01 2007-06-06 KRKA, tovarna zdravil, d.d., Novo mesto Procédé pour la préparation de perindopril et de ses sels
EP2044010B1 (fr) 2006-05-12 2014-01-08 EGIS Gyógyszergyár Nyilvánosan Müködõ Részvénytársaság Nouveaux intermédiaires pharmaceutiques dans la synthèse d'inhibiteurs de l'enzyme de conversion d'angiotensine (ace) et utilisation de ceux-ci
WO2016178591A2 (fr) 2015-05-05 2016-11-10 Gene Predit, Sa Marqueurs génétiques et traitement de l'obésité masculine
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK144769C (da) 1979-12-06 1982-12-13 Voelund Vaskerimaskiner Tromlevaskemaskine med varmeveksler
US4565819A (en) * 1979-12-07 1986-01-21 Adir Substituted imino diacids, their preparation and pharmaceutical compositions which contain them
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
IN156096B (fr) 1981-03-19 1985-05-11 Usv Pharma Corp
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
SI9600169A (en) 1996-05-22 1997-12-31 Krka Tovarna Zdravil Process for preparation of compounds with ace inhibitory effect
FR2807431B1 (fr) 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR2827860B1 (fr) 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril
AR036187A1 (es) 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario

Also Published As

Publication number Publication date
EP1333026B1 (fr) 2007-06-27
WO2003064388A3 (fr) 2004-02-05
CA2474003C (fr) 2009-06-02
SK3292004A3 (en) 2004-12-01
SI1333026T1 (sl) 2007-10-31
SK287866B6 (sk) 2012-02-03
AU2003206055B2 (en) 2008-07-17
PL358514A1 (en) 2003-07-28
EP1333026A1 (fr) 2003-08-06
AP2004003091A0 (en) 2004-09-30
EE200400107A (et) 2004-10-15
KR100673701B1 (ko) 2007-01-24
US7279595B2 (en) 2007-10-09
JP2005521667A (ja) 2005-07-21
AR038340A1 (es) 2005-01-12
MXPA04007444A (es) 2005-06-17
ATE365714T1 (de) 2007-07-15
RS66704A (en) 2007-02-05
CY1106721T1 (el) 2012-05-23
RS52465B (en) 2013-02-28
DE60220877D1 (de) 2007-08-09
HUP0300231A3 (en) 2004-04-28
HRP20040781B1 (en) 2008-12-31
KR20040078680A (ko) 2004-09-10
JP4171423B2 (ja) 2008-10-22
NO20043472L (no) 2004-08-20
HU227591B1 (hu) 2011-09-28
CZ305892B6 (cs) 2016-04-27
HUP0300231A2 (hu) 2003-08-28
ME00444B (fr) 2011-10-10
CZ2004906A3 (cs) 2004-12-15
HRP20040781A2 (en) 2004-12-31
ES2289060T3 (es) 2008-02-01
US7326794B2 (en) 2008-02-05
EA200400929A1 (ru) 2005-06-30
OA12759A (en) 2006-07-04
US20070197821A1 (en) 2007-08-23
EE05428B1 (et) 2011-06-15
BRPI0307293B1 (pt) 2018-03-06
HK1076101A1 (en) 2006-01-06
PT1333026E (pt) 2007-09-17
AP1741A (en) 2007-05-16
HRP20040781A8 (en) 2009-01-31
BR0307293A (pt) 2004-12-21
CN1622936A (zh) 2005-06-01
NO330223B1 (no) 2011-03-07
EA009277B1 (ru) 2007-12-28
ZA200405548B (en) 2006-09-27
BG108858A (en) 2005-05-31
WO2003064388A2 (fr) 2003-08-07
BG66126B1 (bg) 2011-06-30
HRP20040781B8 (en) 2009-01-31
DE60220877T2 (de) 2008-04-10
HU0300231D0 (en) 2003-03-28
UA77756C2 (uk) 2007-01-15
NZ534168A (en) 2006-11-30
US20050119492A1 (en) 2005-06-02
CA2474003A1 (fr) 2003-08-07
PL212354B1 (pl) 2012-09-28
GEP20063899B (en) 2006-08-10
CN1300111C (zh) 2007-02-14

Similar Documents

Publication Publication Date Title
DK1644384T3 (da) Fremgangsmåde og mellemprodukter til syntese af entecavir
DK1657246T3 (da) Fremgangsmåde til forbedring af renhed og udbytte af sucralose
HK1076101A1 (en) Process for the preparation of high purity perindopril and intermediates useful in the synthesis
DK2380568T3 (da) Fremgangsmåde til fremstilling og krystallisation af reduceret coenzyme Q 10
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK1044969T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af anti-cancer forbindelser
IS7261A (is) N-adamantýlmetýlafleiður og milliefni sem lyfjablöndur og aðferðir til að framleiða þær
DK1268424T3 (da) Fremgangsmåde til syntese af perindopril og dets farmaceutisk acceptable salte
IL223579A0 (en) Synthesis of amines and intermediates for the synthesis thereof
NO20051393L (no) Prosess og intermediater for fremstilling av tienopyrrol-derivater
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1420028T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1367061T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
HK1081950A1 (en) 1-Oxa-dibenzoazolenes as inhibitors of thmour necrosis factor production and intermediates for the preparation thereof
NO20044050L (no) Fremgangsmate for syntese av chirale N-aryl-piperaziner
DK1348684T3 (da) Fremgangsmåde til syntese af (2S)-indolin-2-carboxylsyre og anvendelse heraf til syntese af perindopril
ITMI20000026A0 (it) Procedimento per la produzione di gas di sintesi
DK1371659T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1802571T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af derivater af N-(1-benzhydryl-azetidin-3-yl)- N-phenyl-methylsulfonamid
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1420029T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1380591T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutiske acceptable salte heraf
DK1670773T3 (da) Fremgangsmåde til fremstilling af benzoxazol-sulfonamidforbindelser og mellemprodukter deraf
DK1403275T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1367063T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf